FDA HEAD ACKNOWLEDGES A PLAN FOR SAFETY SURVEILLANCE

FDA HEAD ACKNOWLEDGES A PLAN FOR SAFETY SURVEILLANCE Dr. Marion Gruber, Director, Office of Vaccines Research and Review,
Center for Biologics Evaluation and Research, FDA, discusses pharmacological vigilance systems not yet in place, which are essential to “really inform risk management.” DESCRIPTION:
Watch the full exposé here: http://bit.ly/HWEP145

Original source: https://www.youtube.com/watch?v=Er3aX__loWU

Leave a Reply

avatar
  Subscribe  
Notify of

More from Highwire with Del Bigtree: